DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $564,000 | -50.8% | 22,063 | -57.6% | 0.00% | – |
Q4 2020 | $1,146,000 | -18.6% | 51,992 | -33.5% | 0.00% | -100.0% |
Q3 2020 | $1,407,000 | -29.2% | 78,178 | -0.1% | 0.00% | 0.0% |
Q2 2020 | $1,988,000 | +41.2% | 78,278 | +2.2% | 0.00% | 0.0% |
Q1 2020 | $1,408,000 | -42.5% | 76,630 | -11.6% | 0.00% | 0.0% |
Q1 2014 | $2,448,000 | – | 86,678 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |